التفاصيل البيبلوغرافية
| العنوان: |
C-reactive protein as a diagnostic and prognostic factor of endometrial cancer. |
| المؤلفون: |
Socha, Maciej W.1,2 (AUTHOR) msocha@copernicus.gda.pl, Malinowski, Bartosz3 (AUTHOR) bartosz.malin@gmail.com, Puk, Oskar1 (AUTHOR) oskar.trebacz@gmail.com, Wartęga, Mateusz1 (AUTHOR) wartega@gmail.com, Bernard, Piotr1 (AUTHOR) piotr.bernard@cm.umk.pl, Nowaczyk, Monika4 (AUTHOR) mnowaczyk@copernicus.gda.pl, Wolski, Bartłomiej2 (AUTHOR) bwolski@copernicus.gda.pl, Wiciński, Michał3 (AUTHOR) wicinski4@wp.pl |
| المصدر: |
Critical Reviews in Oncology/Hematology. Aug2021, Vol. 164, pN.PAG-N.PAG. 1p. |
| مصطلحات موضوعية: |
*CANCER prognosis, *C-reactive protein, *PROGNOSIS, *CANCER invasiveness, *ENDOMETRIAL cancer, *HEPATORENAL syndrome |
| مستخلص: |
[Display omitted] • C-reactive protein>3.33 mg/l correlates with endometrial cancer incidence. • High sensitivity C-reactive protein may be used for endometrial cancer detection. • C-reactive protein is an independent prognostic factor for endometrial cancer. • Glasgow Prognostic Score have greater prognostic value than C-reactive protein. • C-reactive protein-to-albumin ratio have greater prognostic value than protein alone. Endometrial cancer (EC) is the sixth most commonly occurring cancer in women and its morbidity and mortality are continuously increasing. Considering experience with different types of cancers, C-reactive protein (CRP) appears to be a promising diagnostic and prognostic factor. Aiming to investigate its potential in view of EC authors of this paper reviewed databases for metanalysis, randomized controlled trials and review articles. Studies indicate CRP > 3.33 mg/l correlates with the EC incidence with HR = 2.29 (p < 0.05). Moreover, High-sensitivity CRP assay allows to detect CRP in very low concentrations and distinguish patients with endometriosis, soft tissue sarcomas and possibly EC. Perioperational CRP, as well as its changes are independent prognostic factors for EC. However, CRP-to-albumin ratio as well as Glasgow Prognostic Score (GPS) have greater prognostic value that CRP alone. Additionally, CRP is possibly a mediator of carcinogenesis and cancer progression through activation of inter alia FcgRs/MAPK/ERK, FcgRs/IL-6/AKT/STAT3 and FcgRs/NF-κB/NLRP3 pathways. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |
Full Text Finder